Gynecologic Pathology Masterclass: Contemporary Issues in Light of Shifting Nomenclature, Criteria, and Ancillary Testing
An in-depth gynecologic pathology course focused on evolving terminology, newly characterized entities, updated diagnostic and staging frameworks, molecular diagnostics, biomarker testing, and their impact on modern patient management.
Recorded Package Release: July 1, 2026
Course Co-Directors: Carlos Parra-Herran, MD, and Charles “Matt” Quick, MD
About This Course
Significant updates are occurring throughout the field of gynecologic pathology. The upcoming sixth edition of the World Health Organization Classification of Tumours of Female Reproductive Organs, together with updates to FIGO staging, International Collaboration on Cancer Reporting resources, and current clinical-management guidelines, makes a structured review especially valuable for modern diagnostic practice.
Practicing pathologists and trainees need to understand new terminology, recognize newly characterized entities, and adapt to evolving diagnostic criteria that may directly influence patient management.
Modern classification resources increasingly incorporate molecular markers and biomarker testing to improve diagnosis, risk stratification, prognosis, and targeted treatment selection.
This masterclass helps learners use essential diagnostic resources, interpret classification changes, recognize situations requiring molecular diagnostics, and integrate biomarker results into clinical decision-making.
Why Choose This Course
- Updates related to the sixth edition of the WHO classification
- Current FIGO staging systems, ICCR resources, and management frameworks
- New terminology and newly characterized gynecologic neoplasms
- Molecular diagnostics in ovarian, endometrial, mesenchymal, and gestational lesions
- Biomarker testing in ovarian, endometrial, and cervical cancer
- Practical approaches to non-epithelial and lower genital tract neoplasia
- Dedicated roundtable discussions addressing diagnostic grey areas
- Twenty recorded presentations and twenty course documents
Core Learning Areas
Classification & Staging
WHO classification, FIGO staging, ICCR reporting resources, evolving terminology, and current frameworks for gynecologic cancer diagnosis and management.
Ovarian & Endometrial Pathology
Ovarian epithelial tumors, endometrial pathology, molecular testing, diagnostic criteria, risk stratification, and challenging grey areas.
Non-Epithelial Neoplasia
Mesenchymal tumors, sex-cord stromal tumors, gestational trophoblastic lesions, molecular criteria, and diagnostic alternatives.
Lower Genital Tract Pathology
Cervical, vulvar, and vaginal pathology, modern nomenclature, biomarker testing, ancillary studies, and clinically relevant diagnostic challenges.
Learning Objectives
- Apply essential WHO classification concepts in daily gynecologic pathology practice
- Understand current FIGO staging systems, ICCR resources, and clinical-management guidelines
- Evaluate emerging information on endometrial, upper genital tract, and mesenchymal neoplasia
- Describe newer classification systems and recommended nomenclature for lower genital tract lesions
- Identify non-epithelial gynecologic tumors for which molecular testing is an essential diagnostic criterion
- Develop practical approaches when recommended molecular testing is unavailable
- Discuss biomarker testing in ovarian, endometrial, and cervical cancer
- Integrate molecular and biomarker findings into diagnosis, prognosis, and patient-management decisions
Meet the Faculty
Learn from distinguished specialists in gynecologic pathology, surgical pathology, molecular diagnostics, biomarker testing, and modern tumor classification.
Course Co-Director
Carlos Parra-Herran, MD
Brigham and Women’s Hospital
Harvard Medical School
Course Co-Director
Charles “Matt” Quick, MD
University of Arkansas
for Medical Sciences
Faculty
C. Blake Gilks, MD
Vancouver General Hospital
University of British Columbia
Faculty
Ian S. Hagemann, MD, PhD
Washington University
School of Medicine
Faculty
Brooke E. Howitt, MD
Stanford University
School of Medicine
Faculty
Marilyn A. Kinloch, MD, FRCPC
University of Saskatchewan
Saskatchewan Health Authority
Faculty
Marisa R. Nucci, MD
Harvard Medical School
Dana-Farber Cancer Institute
Complete Curriculum
Pathology of Ovarian Epithelial Tumors
Molecular Testing in Ovarian Cancer
Endometrial Pathology
Molecular Testing in Endometrial Cancer
Roundtable: Grey Areas in Endometrial Pathology
Endometrium
Ovarian Epithelial Lesions
Molecular Testing in Mesenchymal and Gestational Trophoblastic Lesions
Biomarker Testing in Lower Genital Tract Neoplasia
Roundtable: Grey Areas in Ovarian Pathology
Ovarian Non-Epithelial Lesions
Mesenchymal Neoplasms
Pathology of Non-Epithelial Ovarian Tumors
Gynecologic Mesenchymal Neoplasia
Roundtable: Grey Areas in Non-Epithelial Gynecologic Neoplasia
Cervix
Vulva
Pathology of the Uterine Cervix
Vulvo-Vaginal Pathology
Roundtable: Grey Areas in Lower Genital Tract Pathology
Who Should Take This Course
This course is designed for practicing academic and community pathologists, gynecologic pathologists, surgical pathologists, pathology residents, fellows, and pathologists-in-training seeking a structured update on gynecologic tumor classification, molecular diagnostics, biomarker testing, and ancillary studies.
Delivery & Access
Recorded Course
Study the course presentations at your own pace through on-demand access.
20 Presentations
Complete sessions covering ovarian, endometrial, mesenchymal, cervical, vulvar, and vaginal pathology.
20 Course Documents
Accompanying educational documents are included with the course presentations.
Support
Reviews
Verified customer reviews for this course will appear here once they become available.
Reviews
There are no reviews yet.